244 related articles for article (PubMed ID: 12571808)
1. Preclinical and clinical studies with combinations of pemetrexed and gemcitabine.
Adjei AA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):30-4. PubMed ID: 12571808
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine and pemetrexed disodium combinations in vitro and in vivo.
Adjei AA
Lung Cancer; 2001 Dec; 34 Suppl 4():S103-5. PubMed ID: 11742712
[TBL] [Abstract][Full Text] [Related]
3. The pemetrexed/gemcitabine combination in pancreatic cancer.
Kindler HL
Cancer; 2002 Aug; 95(4 Suppl):928-32. PubMed ID: 12209673
[TBL] [Abstract][Full Text] [Related]
4. Pemetrexed in pancreatic cancer.
Kindler HL
Semin Oncol; 2002 Dec; 29(6 Suppl 18):49-53. PubMed ID: 12571811
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies of pemetrexed and gemcitabine combinations.
Adjei AA
Ann Oncol; 2006 May; 17 Suppl 5():v29-32. PubMed ID: 16807459
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
Bunn PA
Semin Oncol; 2002 Jun; 29(3 Suppl 9):17-22. PubMed ID: 12094334
[TBL] [Abstract][Full Text] [Related]
7. Pemetrexed: an active new agent for breast cancer.
O'Shaughnessy JA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):57-62. PubMed ID: 12571813
[TBL] [Abstract][Full Text] [Related]
8. The role of Pemetrexed (Alimta , LY231514) in lung cancer therapy.
Molina JR; Adjei AA
Clin Lung Cancer; 2003 Jul; 5(1):21-7. PubMed ID: 14596699
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent.
Adjei AA
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4276s-4280s. PubMed ID: 15217974
[TBL] [Abstract][Full Text] [Related]
10. Pemetrexed safety and dosing strategy.
Niyikiza C; Hanauske AR; Rusthoven JJ; Calvert AH; Allen R; Paoletti P; Bunn PA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):24-9. PubMed ID: 12571807
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine and Pemetrexed disodium in treating breast cancer.
Adjei AA
Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):34-7. PubMed ID: 11252887
[TBL] [Abstract][Full Text] [Related]
12. The role of pemetrexed combined with gemcitabine for non-small-cell lung cancer.
Ngeow J; Toh CK
Curr Drug Targets; 2010 Jan; 11(1):61-6. PubMed ID: 19839926
[TBL] [Abstract][Full Text] [Related]
13. Pemetrexed in the treatment of selected solid tumors.
Adjei AA
Semin Oncol; 2002 Apr; 29(2 Suppl 5):50-3. PubMed ID: 12023793
[TBL] [Abstract][Full Text] [Related]
14. Biochemical pharmacology of pemetrexed.
Calvert AH
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):13-7. PubMed ID: 15655931
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer.
Le Chevalier T
Semin Oncol; 2003 Aug; 30(4 Suppl 10):37-44. PubMed ID: 12947960
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed (Alimta) and gemcitabine in breast cancer patients previously treated with anthracyclines and taxanes.
Adjei AA
Clin Breast Cancer; 2002 May; 3 Suppl 1():21-3. PubMed ID: 12057041
[TBL] [Abstract][Full Text] [Related]
17. Pemetrexed in pancreatic cancer.
Seitz JF; Dahan L; Ries P
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):43-7. PubMed ID: 15655936
[TBL] [Abstract][Full Text] [Related]
18. New investigative regimens and cytotoxic agents in thoracic cancers: gemcitabine and pemetrexed.
Bunn P
Oncology (Williston Park); 2004 Jul; 18(8 Suppl 5):5-11. PubMed ID: 15339053
[TBL] [Abstract][Full Text] [Related]
19. Pemetrexed in bladder, head and neck, and cervical cancers.
Paz-Ares L; Ciruelos E; García-Carbonero R; Castellano D; Lopez-Martín A; Cortés-Funes H
Semin Oncol; 2002 Dec; 29(6 Suppl 18):69-75. PubMed ID: 12571815
[TBL] [Abstract][Full Text] [Related]
20. The promise of pharmacogenomics: gemcitabine and pemetrexed.
Rosell R; Taron M; Sanchez JM; Moran T; Reguart N; Besse B; Isla D; Massuti B; Alberola V; Sanchez JJ
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):70-6. PubMed ID: 15655942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]